Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-01

Clinical Trial Update: Carbohydrate Consumption as a Factor in Aspart Dosing [Phase 4]

View source ↗

Summary

Phase 4 clinical trial exploring how carbohydrate intake affects Aspart dosing in diabetes; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Rush University Medical Center | Conditions: Diabetes | Phase 4 | Status: TERMINATED | Results posted: 2023-05-01